PRADX and central nervous system cancer: Additionally, ISH assays using 20 low grade glioma tissues, 22 GBM tissues, and 30 COAD and adjacent normal tissues further confirmed the predominant nuclear distribution of PRADX in tumor cells, and indicated its high expression in GBM and COAD (Figure 3C-D, Figure S1D).